Cargando…
Characterization of left ventricular myocardial sodium-glucose cotransporter 1 expression in patients with end-stage heart failure
BACKGROUND: Whereas selective sodium-glucose cotransporter 2 (SGLT2) inhibitors consistently showed cardiovascular protective effects in large outcome trials independent of the presence of type 2 diabetes mellitus (T2DM), the cardiovascular effects of dual SGLT1/2 inhibitors remain to be elucidated....
Autores principales: | Sayour, Alex Ali, Oláh, Attila, Ruppert, Mihály, Barta, Bálint András, Horváth, Eszter Mária, Benke, Kálmán, Pólos, Miklós, Hartyánszky, István, Merkely, Béla, Radovits, Tamás |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7528261/ https://www.ncbi.nlm.nih.gov/pubmed/32998746 http://dx.doi.org/10.1186/s12933-020-01141-1 |
Ejemplares similares
-
Effects of SGLT2 Inhibitors beyond Glycemic Control—Focus on Myocardial SGLT1
por: Sayour, Alex Ali, et al.
Publicado: (2021) -
Left Ventricular SGLT1 Protein Expression Correlates with the Extent of Myocardial Nitro-Oxidative Stress in Rats with Pressure and Volume Overload-Induced Heart Failure
por: Sayour, Alex Ali, et al.
Publicado: (2021) -
Sodium–glucose cotransporter 2 inhibitors reduce myocardial infarct size in preclinical animal models of myocardial ischaemia–reperfusion injury: a meta-analysis
por: Sayour, Alex Ali, et al.
Publicado: (2021) -
Pharmacological preconditioning with gemfibrozil preserves cardiac function after heart transplantation
por: Benke, Kálmán, et al.
Publicado: (2017) -
Stimulation of soluble guanylate cyclase improves donor organ function in rat heart transplantation
por: Benke, Kálmán, et al.
Publicado: (2020)